KOPRAN
Back to Cashflow Statement
|
KOPRAN Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹67 Cr | ₹42 Cr | ₹43 Cr | ₹34 Cr | ₹-33 Cr |
What is the latest Cash Flow from Operating Activities ratio of KOPRAN ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹67 Cr |
| Mar2025 | ₹42 Cr |
| Mar2024 | ₹43 Cr |
| Mar2023 | ₹34 Cr |
| Mar2022 | ₹-33 Cr |
How is Cash Flow from Operating Activities of KOPRAN Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹67 Cr | 59.15 | |
| Mar2025 | ₹42 Cr | -3.04 | |
| Mar2024 | ₹43 Cr | 27.14 | |
| Mar2023 | ₹34 Cr | Positive | |
| Mar2022 | ₹-33 Cr | - | |
Compare Cash Flow from Operating Activities of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹967.0 Cr | 5.3% | -0.8% | 29.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | -1.2% | -2.2% | 15.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹227,958.0 Cr | 1% | 16.3% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,990.0 Cr | 3.2% | -0.8% | 38.6% | Stock Analytics | |
| CIPLA | ₹116,141.0 Cr | -0.9% | 1.6% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,604.4 Cr | -1.7% | -0.1% | -6.5% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | 5.3% |
-0.8% |
29.2% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
You may also like the below Video Courses